Literature DB >> 11157997

Pathophysiology of X-linked hypophosphatemia, tumor-induced osteomalacia, and autosomal dominant hypophosphatemia: a perPHEXing problem.

L D Quarles, M K Drezner.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11157997     DOI: 10.1210/jcem.86.2.7302

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  15 in total

Review 1.  Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.

Authors:  Marie Courbebaisse; Beate Lanske
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

2.  Evidence for a bone-kidney axis regulating phosphate homeostasis.

Authors:  L Darryl Quarles
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 3.  Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism.

Authors:  L Darryl Quarles
Journal:  Nat Rev Endocrinol       Date:  2012-01-17       Impact factor: 43.330

4.  Conventional Therapy in Adults With X-Linked Hypophosphatemia: Effects on Enthesopathy and Dental Disease.

Authors:  Jessica Connor; Elizabeth A Olear; Karl L Insogna; Lee Katz; Suher Baker; Raghbir Kaur; Christine A Simpson; John Sterpka; Robert Dubrow; Jane H Zhang; Thomas O Carpenter
Journal:  J Clin Endocrinol Metab       Date:  2015-07-15       Impact factor: 5.958

5.  Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets.

Authors:  Doron Bresler; Jan Bruder; Klaus Mohnike; William D Fraser; Peter S N Rowe
Journal:  J Endocrinol       Date:  2004-12       Impact factor: 4.286

6.  Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein.

Authors:  Marcelo Campos; Constance Couture; Izaura Y Hirata; Maria A Juliano; Thomas P Loisel; Philippe Crine; Luiz Juliano; Guy Boileau; Adriana K Carmona
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

7.  Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP).

Authors:  Peter S N Rowe; Ian R Garrett; Patricia M Schwarz; David L Carnes; Eileen M Lafer; Gregory R Mundy; Gloria E Gutierrez
Journal:  Bone       Date:  2004-11-24       Impact factor: 4.398

8.  FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation.

Authors:  Sangeeta Pande; Cynthia S Ritter; Marcos Rothstein; Karen Wiesen; John Vassiliadis; Rajiv Kumar; Susan C Schiavi; Eduardo Slatapolsky; Alex J Brown
Journal:  Nephron Physiol       Date:  2006-05-10

Review 9.  The wrickkened pathways of FGF23, MEPE and PHEX.

Authors:  Peter S N Rowe
Journal:  Crit Rev Oral Biol Med       Date:  2004-09-01

10.  IL-1β Drives Production of FGF-23 at the Onset of Chronic Kidney Disease in Mice.

Authors:  Quiana McKnight; Sarah Jenkins; Xiuqi Li; Tracy Nelson; Arnaud Marlier; Lloyd G Cantley; Karin E Finberg; Jackie A Fretz
Journal:  J Bone Miner Res       Date:  2020-05-27       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.